Supernus Pharmaceuticals
SUPN
SUPN
275 hedge funds and large institutions have $2.03B invested in Supernus Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 92 increasing their positions, 111 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 111
36% less call options, than puts
Call options by funds: $6.34M | Put options by funds: $9.84M
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
275
Holding in Top 10
4
Calls
$6.34M
Puts
$9.84M
Top Buyers
| 1 | +$39.5M | |
| 2 | +$21M | |
| 3 | +$19.4M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$16M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$16M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$14.1M | |
| 3 | -$12.1M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$10.5M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.81M |